Penn Today Online

Related Links
Find an Ob/Gyn
Make a Referral Online or call 1-800-789-PENN
Penn Ob/Gyn Care
Penn Fertility Care
Patient Education Articles about Women's Health
 

 


 Penn Today Online

Current Issue
Bloodless Robotic Surgery for Gynecologic Cancers
Good Shepherd Rehabilitation Network & Penn Medicine: Partners in Post-Acute Care
Importance of Evaluation for Obstructive Sleep Apnea in Obese Patients with Type 2 Diabetes
Physician Announcements
Archive of Articles
 
Subscribe to the Newsletter
Newsletter RSS Feed RSS feed
   

Home
Penn Today Online
Referral Directory
Physician Tools
Urgent Patient Transfer
Research
Upcoming CMEs

Ovum Cryopreservation: Reality or Hype?

March / April 2005

Whether to preserve a female cancer patient’s eggs until cancer treatment is completed or to allow a woman to prolong her fertility while postponing childbearing, the cryopreservation of oocytes or ovarian tissue, is an important area of research for reproductive endocrinologists. Cryopreservation is a precise method used to preserve embryos, eggs, ovarian tissue and sperm by cooling and storing them at a low temperature and then thawing them for future use.

Today, cryo-egg clinics are becoming more common and many women and couples are hoping to successfully freeze their eggs and defer pregnancy. “The reality is that in human studies, millions and millions of eggs have been cryopreserved with just a handful of babies born. So the efficiency of this system — the starting number of eggs to number of babies born — is rather discouraging,” says Christos Coutifaris, MD, PhD, director of the Penn Center for Reproductive Medicine and Surgery and professor of obstetrics and gynecology at the University of Pennsylvania Health System. “This is in sharp contrast to the relatively highly successful freezing and thawing of embryos (not eggs).”

Although to date no babies have been born utilizing preserved ovarian tissue, animal studies suggest that this method holds more promise than the cryopreservation of single oocytes. In Europe, a cancer patient had healthy ovarian tissue cryopreserved and then transplanted back into an ovary where ovulation later occurred. Although not conclusive, experts agree that the ovary with the transplanted ovarian tissue produced the ovulation.

“Normal egg maturation depends on the three-dimensional structure of the ovary and the different interactions between the egg and surrounding ovarian cells. That’s why cryopreservation of ovarian tissue is more appropriate than cryopreservation of eggs,” adds Dr. Coutifaris.

A September 2004 practice bulletin from the American Society for Reproductive Medicine concluded that the cryopreservation of both eggs and ovarian tissue for cancer patients holds great promise, but at this time should remain an investigational procedure with strict oversight and be provided at no charge to patients. The report further concluded that neither oocyte nor ovarian tissue preservation should be offered or marketed as a means to defer reproductive aging.

“Women and couples seeking ovum cryopreservation are extremely vulnerable and are often willing to invest an exorbitant amount of money in this technology even though it has a very low chance of success,” adds Dr. Coutifaris. “It is important for primary care physicians to know the facts about fertility and age, provide their patients with realistic expectations, and refer their patients to a board-certified fertility specialist if they are over age 30 and are having trouble conceiving.”

Women are born with approximately one million follicles in their ovaries and by puberty just 300,000 remain. This number continues to decline until menopause when almost no follicles are left in the ovaries. “For women with a diminished ovarian reserve or who are experiencing early menopause, or who have undergone cancer treatment, using eggs donated by a young, healthy woman is the best chance for conception and a live-birth,” says Dr. Coutifaris. Recent national data showed an approximate 50 percent live-birth rate for patients over age 38 who used fresh donor eggs.

“The use of donor eggs allows a dramatic increase in the chance a woman will conceive because the age of the donor determines the success of the cycle, not the age of the recipient. Therefore, if a 41-year-old woman selects a 24-year-old donor, her pregnancy success rate will be that of a 24-year-old woman as long as the recipient has a normal uterus,” explains Dr. Coutifaris.

Penn is one of only eight centers in the nation funded by the National Institutes of Health (NIH) to perform clinical infertility research and the only center funded by the NIH for laboratory research specifically related to infertility.

When Should Your Patient See a Fertility Specialist?

  • If the woman is under age 35 and has not conceived after a year of trying to get pregnant.
  • If the woman is over age 35 and has been unable to conceive after six months of trying.
  • If the woman has lost two or more pregnancies to miscarriage.
  • If other infertility treatments have not been successful.
  • If the patient does not have regular menstrual cycles, or has had a prior gynecological problem (e.g. endometriosis, tubal pregnancy, pelvic surgery or infections), she should seek assistance sooner.

 


Referring Physicians: To speak with a Penn physician or refer a patient, contact PennHealth through the secure online referral form or by calling
1-800-789-PENN (7366).

   
   

 

About Penn Medicine   Contact Us   Site Map   Privacy Statement   Legal Disclaimer   Terms of Use

Penn Medicine, Philadelphia, PA 800-789-PENN © 2010, The Trustees of the University of Pennsylvania space